Medical devices, healthcare technology and the business of care
COMPANY INTELLIGENCE

Abbott Vascular Devices

Explore this company’s associated devices, FDA decisions and regulatory history.

Clinical monitoring equipment, editorial photography

Abbott Vascular Devices

Regulatory records
3
Linked recall entries
0
Headquarters
Not reported
Brand website
Not reported
COMPANY INTELLIGENCE

What the linked records show

MedtechLedger currently links 3 FDA records to the applicant name Abbott Vascular Devices. 1 entry is a PMA supplement. 2 entries are 30-day notices. These are records held by this publication, rather than a count of the company’s entire portfolio.

The dated entries run from Dec 9, 2025 to Apr 17, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.

Product code MGB appears in 3 of the 3 linked filings. The collection spans 1 FDA product code and 1 original PMA application family. These figures describe the filings available here; they do not establish the company’s total device sales or market share.

The largest PMA family in this collection is P050007, with 3 linked entries. Follow the parent application and its dated supplements to distinguish the original device scope from later changes.

Applicant mailing address recorded by FDA: 3200 Lakeside Dr., Santa Clara, CA, 95054. Recorded on P050007/S049, decision dated Apr 17, 2026.

Changes described in PMA records

P050007/S048: StarClose SE Vascular Closure System

FDA’s recorded scope: a modification to the sustainable ethylene oxide (SEO) cycle previously approved for Line 1, Line 2, Line 14 and Line 15 at Synergy Health Ireland and implementation of the SEO cycle at Sterigenics Los Angeles

Mar 2, 2026 · 30-Day Notice

P050007/S047: StarClose SE Vascular Surgical System

FDA’s recorded scope: approval for a manufacturing site located at Synergy Health AST, SRL, B13.1 Street 4, Avenue 1, Coyol Free Zone, Coyol, Alajuela, 20102, Costa Rica for sterilization.

Dec 9, 2025 · Normal 180 Day Track No User Fee

Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.

Regulatory record history

Product / regulatory recordCompanyPathwayDecision dateSource
Abbott Vascular DevicesPMA supplementApr 17, 2026FDA
Abbott Vascular DevicesPMA supplementMar 2, 2026FDA
Abbott Vascular DevicesPMA supplementDec 9, 2025FDA
Source information

Source updated Nov 9, 2026. Retrieved Nov 21, 2026.